CN1484528A - 包括南荛脂素和/或罗汉松脂素的药物组合物其作为肝保护剂的用途和从雪松中分离它们的方法 - Google Patents
包括南荛脂素和/或罗汉松脂素的药物组合物其作为肝保护剂的用途和从雪松中分离它们的方法 Download PDFInfo
- Publication number
- CN1484528A CN1484528A CNA008199817A CN00819981A CN1484528A CN 1484528 A CN1484528 A CN 1484528A CN A008199817 A CNA008199817 A CN A008199817A CN 00819981 A CN00819981 A CN 00819981A CN 1484528 A CN1484528 A CN 1484528A
- Authority
- CN
- China
- Prior art keywords
- wikstromol
- martairesinol
- additive
- purposes
- compositions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- ZITBJWXLODLDRH-UHFFFAOYSA-N (+)--Wikstromol Natural products C1=C(O)C(OC)=CC(CC2C(C(=O)OC2)(O)CC=2C=C(OC)C(O)=CC=2)=C1 ZITBJWXLODLDRH-UHFFFAOYSA-N 0.000 title claims abstract description 85
- 238000000034 method Methods 0.000 title claims description 31
- 239000008194 pharmaceutical composition Substances 0.000 title claims description 5
- 238000002955 isolation Methods 0.000 title abstract 2
- ZITBJWXLODLDRH-VLIAUNLRSA-N 3-hydroxy-3,4-bis[(4-hydroxy-3-methoxyphenyl)methyl]oxolan-2-one Chemical compound C1=C(O)C(OC)=CC(C[C@H]2[C@@](C(=O)OC2)(O)CC=2C=C(OC)C(O)=CC=2)=C1 ZITBJWXLODLDRH-VLIAUNLRSA-N 0.000 title description 6
- FWKQNCXZGNBPFD-UHFFFAOYSA-N Guaiazulene Chemical compound CC(C)C1=CC=C(C)C2=CC=C(C)C2=C1 FWKQNCXZGNBPFD-UHFFFAOYSA-N 0.000 title 1
- ZITBJWXLODLDRH-XOBRGWDASA-N (-)-Nortrachelogenin Natural products C1=C(O)C(OC)=CC(C[C@@H]2[C@@](C(=O)OC2)(O)CC=2C=C(OC)C(O)=CC=2)=C1 ZITBJWXLODLDRH-XOBRGWDASA-N 0.000 claims abstract description 77
- 239000000654 additive Substances 0.000 claims abstract description 28
- 150000001875 compounds Chemical class 0.000 claims abstract description 28
- 239000003963 antioxidant agent Substances 0.000 claims abstract description 18
- 230000002443 hepatoprotective effect Effects 0.000 claims abstract description 10
- 230000000996 additive effect Effects 0.000 claims description 27
- 239000000203 mixture Substances 0.000 claims description 26
- 241000218645 Cedrus Species 0.000 claims description 24
- 230000003078 antioxidant effect Effects 0.000 claims description 20
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 18
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 18
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 13
- 239000002516 radical scavenger Substances 0.000 claims description 12
- 229940123457 Free radical scavenger Drugs 0.000 claims description 11
- 241000196324 Embryophyta Species 0.000 claims description 9
- 230000000694 effects Effects 0.000 claims description 9
- 206010003210 Arteriosclerosis Diseases 0.000 claims description 6
- 208000011775 arteriosclerosis disease Diseases 0.000 claims description 6
- 239000000284 extract Substances 0.000 claims description 6
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical group CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims description 5
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 claims description 4
- 238000005160 1H NMR spectroscopy Methods 0.000 claims description 4
- 230000003203 everyday effect Effects 0.000 claims description 4
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims description 4
- 239000002904 solvent Substances 0.000 claims description 4
- 239000000126 substance Substances 0.000 claims description 3
- 229910014033 C-OH Inorganic materials 0.000 claims description 2
- 229910014570 C—OH Inorganic materials 0.000 claims description 2
- 125000000457 gamma-lactone group Chemical group 0.000 claims description 2
- 238000000638 solvent extraction Methods 0.000 claims description 2
- 125000000837 carbohydrate group Chemical group 0.000 claims 5
- 235000014633 carbohydrates Nutrition 0.000 claims 5
- 235000015097 nutrients Nutrition 0.000 claims 5
- 102000004169 proteins and genes Human genes 0.000 claims 5
- 108090000623 proteins and genes Proteins 0.000 claims 5
- 239000003937 drug carrier Substances 0.000 claims 4
- 238000007796 conventional method Methods 0.000 claims 1
- 239000000890 drug combination Substances 0.000 claims 1
- 238000010828 elution Methods 0.000 claims 1
- 239000002398 materia medica Substances 0.000 claims 1
- 239000002699 waste material Substances 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 abstract description 3
- MATGKVZWFZHCLI-LSDHHAIUSA-N (-)-matairesinol Chemical compound C1=C(O)C(OC)=CC(C[C@@H]2[C@H](C(=O)OC2)CC=2C=C(OC)C(O)=CC=2)=C1 MATGKVZWFZHCLI-LSDHHAIUSA-N 0.000 abstract 2
- 235000006708 antioxidants Nutrition 0.000 description 15
- 150000003254 radicals Chemical class 0.000 description 13
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 9
- 239000003921 oil Substances 0.000 description 7
- 238000000605 extraction Methods 0.000 description 6
- 230000003064 anti-oxidating effect Effects 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 238000011160 research Methods 0.000 description 5
- 102100036475 Alanine aminotransferase 1 Human genes 0.000 description 4
- 108010082126 Alanine transaminase Proteins 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 3
- 108010003415 Aspartate Aminotransferases Proteins 0.000 description 3
- 102000004625 Aspartate Aminotransferases Human genes 0.000 description 3
- 230000001404 mediated effect Effects 0.000 description 3
- 231100000572 poisoning Toxicity 0.000 description 3
- 230000000607 poisoning effect Effects 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 3
- ZITBJWXLODLDRH-JLTOFOAXSA-N (+)-Wikstromol Natural products C1=C(O)C(OC)=CC(C[C@H]2[C@](C(=O)OC2)(O)CC=2C=C(OC)C(O)=CC=2)=C1 ZITBJWXLODLDRH-JLTOFOAXSA-N 0.000 description 2
- -1 (-)-wikstromol free radical Chemical class 0.000 description 2
- ZITBJWXLODLDRH-VBKZILBWSA-N (3R,4S)-3-hydroxy-3,4-bis[(4-hydroxy-3-methoxyphenyl)methyl]oxolan-2-one Chemical compound C1=C(O)C(OC)=CC(C[C@@H]2[C@](C(=O)OC2)(O)CC=2C=C(OC)C(O)=CC=2)=C1 ZITBJWXLODLDRH-VBKZILBWSA-N 0.000 description 2
- 244000068687 Amelanchier alnifolia Species 0.000 description 2
- 235000009027 Amelanchier alnifolia Nutrition 0.000 description 2
- INPPVVSEQRZCLJ-UHFFFAOYSA-N Carinol Chemical compound C1=C(O)C(OC)=CC(CC(CO)C(O)(CO)CC=2C=C(OC)C(O)=CC=2)=C1 INPPVVSEQRZCLJ-UHFFFAOYSA-N 0.000 description 2
- 240000009248 Carissa edulis Species 0.000 description 2
- 235000012937 Carissa edulis Nutrition 0.000 description 2
- LHQJDCXEZZAFKD-UHFFFAOYSA-N Carissanol Chemical compound C1=C(O)C(OC)=CC(CC2C(C(O)OC2)(O)CC=2C=C(OC)C(O)=CC=2)=C1 LHQJDCXEZZAFKD-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 2
- 238000002372 labelling Methods 0.000 description 2
- 229930013686 lignan Natural products 0.000 description 2
- 235000009408 lignans Nutrition 0.000 description 2
- 150000005692 lignans Chemical class 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 230000001590 oxidative effect Effects 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 238000012856 packing Methods 0.000 description 2
- 235000017807 phytochemicals Nutrition 0.000 description 2
- 229930000223 plant secondary metabolite Natural products 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- SBVBJPHMDABKJV-PGCJWIIOSA-N secoisolariciresinol diglucoside Chemical compound C1=C(O)C(OC)=CC(C[C@@H](CO[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)[C@H](CO[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)CC=2C=C(OC)C(O)=CC=2)=C1 SBVBJPHMDABKJV-PGCJWIIOSA-N 0.000 description 2
- SBVBJPHMDABKJV-UHFFFAOYSA-N secoisolariciresinol diglycoside Natural products C1=C(O)C(OC)=CC(CC(COC2C(C(O)C(O)C(CO)O2)O)C(COC2C(C(O)C(O)C(CO)O2)O)CC=2C=C(OC)C(O)=CC=2)=C1 SBVBJPHMDABKJV-UHFFFAOYSA-N 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 239000002023 wood Substances 0.000 description 2
- NVKAWKQGWWIWPM-ABEVXSGRSA-N 17-β-hydroxy-5-α-Androstan-3-one Chemical compound C1C(=O)CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CC[C@H]21 NVKAWKQGWWIWPM-ABEVXSGRSA-N 0.000 description 1
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- 102000001707 3',5'-Cyclic-AMP Phosphodiesterases Human genes 0.000 description 1
- 108010054479 3',5'-Cyclic-AMP Phosphodiesterases Proteins 0.000 description 1
- 108700016171 Aspartate ammonia-lyases Proteins 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- NZRLODDQFPZTPM-UHFFFAOYSA-N Cedrin Natural products OC1C(=O)C2=C(O)C(C)=C(O)C=C2OC1C1=CC(O)=C(O)C(O)=C1 NZRLODDQFPZTPM-UHFFFAOYSA-N 0.000 description 1
- 241000218646 Cedrus deodara Species 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 241000218631 Coniferophyta Species 0.000 description 1
- 206010048768 Dermatosis Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 241000628997 Flos Species 0.000 description 1
- 101600111816 Homo sapiens Sex hormone-binding globulin (isoform 1) Proteins 0.000 description 1
- 208000035150 Hypercholesterolemia Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 240000006240 Linum usitatissimum Species 0.000 description 1
- 235000004431 Linum usitatissimum Nutrition 0.000 description 1
- 208000028018 Lymphocytic leukaemia Diseases 0.000 description 1
- 241000218922 Magnoliophyta Species 0.000 description 1
- 241000700157 Rattus norvegicus Species 0.000 description 1
- 241001474728 Satyrodes eurydice Species 0.000 description 1
- 102300044179 Sex hormone-binding globulin isoform 1 Human genes 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- YFVZKLQNMNKWSB-UHFFFAOYSA-N Trachelogenin Natural products C1=C(O)C(OC)=CC(CC2(O)C(OCC2CC=2C=C(OC)C(OC)=CC=2)=O)=C1 YFVZKLQNMNKWSB-UHFFFAOYSA-N 0.000 description 1
- 108090000340 Transaminases Proteins 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 244000060545 Wikstroemia viridiflora Species 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 229940087168 alpha tocopherol Drugs 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000003178 anti-diabetic effect Effects 0.000 description 1
- 230000036436 anti-hiv Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 239000003472 antidiabetic agent Substances 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 230000002026 carminative effect Effects 0.000 description 1
- 238000010523 cascade reaction Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000002026 chloroform extract Substances 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 235000008504 concentrate Nutrition 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 238000003920 environmental process Methods 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 235000012055 fruits and vegetables Nutrition 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 231100000334 hepatotoxic Toxicity 0.000 description 1
- 230000003082 hepatotoxic effect Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 208000003747 lymphoid leukemia Diseases 0.000 description 1
- OGFXBIXJCWAUCH-UHFFFAOYSA-N meso-secoisolariciresinol Natural products C1=2C=C(O)C(OC)=CC=2CC(CO)C(CO)C1C1=CC=C(O)C(OC)=C1 OGFXBIXJCWAUCH-UHFFFAOYSA-N 0.000 description 1
- 235000013379 molasses Nutrition 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 235000014593 oils and fats Nutrition 0.000 description 1
- 239000008601 oleoresin Substances 0.000 description 1
- 210000004279 orbit Anatomy 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000002685 pulmonary effect Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000013207 serial dilution Methods 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229960001866 silicon dioxide Drugs 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 229960000984 tocofersolan Drugs 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 102000014898 transaminase activity proteins Human genes 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 239000005418 vegetable material Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 239000002076 α-tocopherol Substances 0.000 description 1
- 235000004835 α-tocopherol Nutrition 0.000 description 1
Images
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Furan Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
表1 | AST(U/L) | ALT(U/L) | ||
先前 | 先后 | 先前 | 先后 | |
CCl4对照 | 233±139(10) | 686±142(10) | 37±9(10) | 273±80(10) |
(-)-南荛脂素处理+CCl4 | 281±91(5) | 557±126(5) | 42±7(5) | 188±66(5) |
Claims (38)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/IN2000/000104 WO2002034277A1 (en) | 2000-10-23 | 2000-10-23 | Pharmaceutical composition comprising wikstromol and/or matairesinol, its use as hepatoprotectant and process for their isolation from cedrus deodara |
Publications (1)
Publication Number | Publication Date |
---|---|
CN1484528A true CN1484528A (zh) | 2004-03-24 |
Family
ID=11076278
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNA008199817A Pending CN1484528A (zh) | 2000-10-23 | 2000-10-23 | 包括南荛脂素和/或罗汉松脂素的药物组合物其作为肝保护剂的用途和从雪松中分离它们的方法 |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1313490A1 (zh) |
JP (1) | JP2004512308A (zh) |
CN (1) | CN1484528A (zh) |
BR (1) | BR0017334A (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103239560A (zh) * | 2013-04-27 | 2013-08-14 | 黄美华 | 用于护肝保肝的组合物及其药贴和药油 |
CN107595833A (zh) * | 2017-10-31 | 2018-01-19 | 上海华堇生物技术有限责任公司 | 雪松素的药物用途 |
CN114392287A (zh) * | 2022-01-28 | 2022-04-26 | 国珍健康科技(北京)有限公司 | 一种抑制5α还原酶活性的松针提取物及其制备方法和应用 |
-
2000
- 2000-10-23 JP JP2002537328A patent/JP2004512308A/ja active Pending
- 2000-10-23 BR BR0017334-7A patent/BR0017334A/pt not_active IP Right Cessation
- 2000-10-23 EP EP00991822A patent/EP1313490A1/en not_active Withdrawn
- 2000-10-23 CN CNA008199817A patent/CN1484528A/zh active Pending
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103239560A (zh) * | 2013-04-27 | 2013-08-14 | 黄美华 | 用于护肝保肝的组合物及其药贴和药油 |
CN103239560B (zh) * | 2013-04-27 | 2014-10-01 | 黄美华 | 用于护肝保肝的组合物及其药贴和药油 |
CN107595833A (zh) * | 2017-10-31 | 2018-01-19 | 上海华堇生物技术有限责任公司 | 雪松素的药物用途 |
CN114392287A (zh) * | 2022-01-28 | 2022-04-26 | 国珍健康科技(北京)有限公司 | 一种抑制5α还原酶活性的松针提取物及其制备方法和应用 |
Also Published As
Publication number | Publication date |
---|---|
EP1313490A1 (en) | 2003-05-28 |
BR0017334A (pt) | 2004-07-06 |
JP2004512308A (ja) | 2004-04-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1853682A (zh) | 用于改善睡眠持续时间和质量的基于植物的食品强化剂 | |
WO2014044744A1 (en) | NOVEL EXTRACTS OF CYNARA SCOLYMUS, COFFEA spp. AND OLEA EUROPAEA FOR THE TREATMENT OF METABOLIC SYNDROME | |
CN1813900A (zh) | 南五味子木脂素的提取物及其制备方法和用途 | |
CN1392167A (zh) | 银杏叶聚戊烯醇和银杏叶提取物(gbe)的制备方法及其用途 | |
CN101067004A (zh) | 一种艾叶多糖及其用途 | |
CN1923193A (zh) | 一种香豆素类化合物在制备抗炎镇痛药物中的应用 | |
CN1484528A (zh) | 包括南荛脂素和/或罗汉松脂素的药物组合物其作为肝保护剂的用途和从雪松中分离它们的方法 | |
JP2002205949A (ja) | 代謝異常改善方法およびそのための組成物 | |
CN1141101C (zh) | 治疗乙肝的药物及其制备方法 | |
CN1233401C (zh) | 藿香正气胶囊及其制备方法 | |
CA2454786C (en) | Pharmaceutical composition comprising (-)-secoisolariciresinol | |
US6458831B1 (en) | Use of two plant phenols in the treatment of arteriosclerosis | |
US6537593B2 (en) | Plant phenol as new hepatoprotective agents | |
CN1176677C (zh) | 一种治疗冠心病的中药组合物及其制剂和制备方法 | |
CN1489994A (zh) | 姜黄脂溶性苯丙乙烯类成分提取物及其制剂新用途 | |
CN1557824A (zh) | 蚕沙总生物碱及其制备方法 | |
CA2455566C (en) | (+)-cycloolivil as antioxidant obtained from stereospermum personatum | |
CN1176939C (zh) | 猪牙皂总皂苷及其制备方法与其在制备药物中的应用 | |
CN1634330A (zh) | 复方柴胡药物制剂 | |
JP2009269896A (ja) | 抗糖尿病食品または医薬品素材及び抗糖尿病食品または医薬品 | |
CN114588149A (zh) | 毛裂蜂斗菜总内酯及蜂斗菜内酯类化合物在制备提高运动能力药物中的应用 | |
EP1411919B1 (en) | (-)-olivil as antioxidant | |
Rao et al. | Olivil as antioxidant which is obtained from a new natural source namely Stereospermum personatum | |
CN1520826A (zh) | 一种提高沙棘黄酮生物利用度的药用组合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH; AP Free format text: FORMER OWNER: COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH Effective date: 20060224 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20060224 Address after: India New Delhi Applicant after: Council of Scientific and Industrial Research Co-applicant after: A Ya Wei Diya Salad company Address before: India New Delhi Applicant before: Council of Scientific and Industrial Research |
|
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |